2
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Breast
1
Conditions
Pancreatic Neoplasms
9
Peutz-Jeghers Syndrome
3
Exocrine Pancreatic Insufficiency
2
Pancreatic Intraductal Neoplasms
1
Intraductal Papillary Mucinous Neoplasms
1
Hereditary pancreatitis
1
Hereditary Sensory and Autonomic Neuropathies
1
Fanconi Anemia, Complementation Group D1
1
Dysplastic Nevus Syndrome
1
Diabetes Mellitus
1
Colorectal Neoplasms, Hereditary Nonpolyposis
1
Breast Neoplasms
1
Interventions
Surveys and Questionnaires
10
Colonoscopy
6
Specimen Handling
5
Observation
4
Genetic Testing
4
Magnetic Resonance Spectroscopy
3
Interviews as Topic
3
High-Throughput Nucleotide Sequencing
3
Genetic Counseling
3
Endoscopy
3
Biopsy
3
Nivolumab
2
Naproxen
2
Mesalamine
2
Educational Status
2
Aspirin
2
toripalimab
1
tislelizumab
1
spartalizumab
1
pembrolizumab
1
dehydroftorafur
1
atezolizumab
1
acetylsalicylic acid lysinate
1
Telemedicine
1
Taxes
1
Secretin
1
Salpingo-oophorectomy
1
RAD51C protein, human
1
Physical Examination
1
Patient Navigation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Colorectal Neoplasms, Hereditary Nonpolyposis
×
Secretin
×
Clear all
NCT02000089
2025-10-09
CAPS5
Johns Hopkins University
Phase 3
Recruiting
9,000 enrolled